Clinical Trials Logo

Cognition Disorders clinical trials

View clinical trials related to Cognition Disorders.

Filter by:

NCT ID: NCT03479970 Active, not recruiting - Cognition Disorders Clinical Trials

Rehabilitation of Social Cognition in Subjects With Traumatic Brain Injury

SOCCER
Start date: January 2, 2018
Phase: N/A
Study type: Interventional

In the present study the investigators aim to analyze the performance in a battery of social cognition tests of subjects with traumatic brain injury. On the other hand, the effectiveness of a computerized rehabilitation program designed to improve these deficits will be tested, as well as the relationship between social cognition and executive functioning.

NCT ID: NCT03221452 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Adaptation of a Cognitive Training Intervention for Diabetes Self-Management

Start date: September 2, 2016
Phase: N/A
Study type: Interventional

The aims of this project are: (1) to refine an existing cognitive rehabilitation intervention and tailor it for persons with T2DM by using current literature and interview data from 10 participants with T2DM and (2) to conduct a feasibility study of the adapted intervention with 20 participants with T2DM. The intervention consists of 8 weekly group educational sessions to teach compensatory cognitive strategies. Participants will also use a web-based, game-like program to build on the didactic information and practice activities to improve cognitive health.

NCT ID: NCT03205709 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment

CogTraining
Start date: November 29, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if systematic cognitive training can improve cognitive performance in participants (55 and older) with memory loss. This study will evaluate the effects of Computerized Cognitive Training (CCT) for improvement in everyday cognitive and function status, in addition to long-term changes in brain networks over an 18-month period. Although there is no distribution of medication for this study, participants are required to have an at-home computer.

NCT ID: NCT02847403 Active, not recruiting - Dysglycemia Clinical Trials

Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients

DRINN
Start date: February 2016
Phase: Phase 3
Study type: Interventional

The overall objective of the study is to assess the potential effects of the long-acting GLP-1 analogue exenatide in preventing/slowing the progression of cognitive dysfunction and related biomarkers in dysglycemic/prediabetic patients with mild cognitive impairment (MCI).

NCT ID: NCT02753036 Active, not recruiting - Cognition Disorders Clinical Trials

Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer

CICARO
Start date: January 1, 2016
Phase:
Study type: Observational

Neurotoxic phenomena are among the most common and difficult to treat side effects of chemotherapy. The development of chemotherapy induced peripheral neuropathy (CIPN) is a well-recognized adverse reaction in the peripheral nervous system. Side effects of chemotherapy in the central nervous system, however, particularly changes of cognitive function (in non-medical literature referred to as "chemobrain") are diffuse and difficult to attribute to individual cytostatic drugs. The primary purpose of this study is to assess cognitive function in patients with ovarian and breast cancer before and after systemic chemotherapy with paclitaxel with standardized neuropsychological tests and compare the outcome to patients with benign gynecological tumors and breast cancer without chemotherapy treatment, respectively. Secondary parameters include the assessment of olfactory function, total neuropathy score and cytokine profiles.

NCT ID: NCT02300896 Active, not recruiting - Clinical trials for Cognitive Impairment

Functional and Cognitive Impairment Prevention for Elderly Hospitalized Patients

Start date: March 2015
Phase: N/A
Study type: Interventional

The current model of care for the hospitalized elderly patients has been conditioned by many factors unrelated to the disease process that caused the hospitalization and usually worsen the outcome of hospitalization circumstances. Many times hospitalized elderly patients spend most of the time in bed (even higher than 83% of bed rest versus 4% of those who stand or are walking). These patients have their functional and physiological reserve reduced which makes them more vulnerable to the effects of being bedridden. The consequences are at multiple levels emphasizing the functional loss or cognitive impairment, longer stays, mortality and institutionalization, delirium, deconditioning, pressure ulcers and decreased caloric intake, social isolation, poor quality of life and increased use of resources related to health. Exercise training can prevent functional and cognitive decline and modify even the posterior trajectory.

NCT ID: NCT02193906 Active, not recruiting - Clinical trials for Cognitive Dysfunction

Neuropsychological Profile of a Patient's Group With Multiple Sclerosis and Effect of a Cognitive Rehabilitation Program

MS_Rehab
Start date: December 2012
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the effect of an web-based intensive cognitive rehabilitation program in neuropsychological performance of a population of patients with multiple sclerosis or clinical isolated syndrome.

NCT ID: NCT02190019 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment:Pilot Study

Start date: April 2014
Phase: Phase 4
Study type: Interventional

Mild cognitive impairment (MCI) is a precursor of dementia. Apathy, a profound loss of motivation, is a common behavioral problem in MCI. Presence of apathy may increase the chance of MCI patients converting to Alzheimer's Dementia. Repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive tool, has been recently approved for treatment of refractory depression. Since dysfunction in the frontal lobe of the brain is seen in patients with apathy, rTMS to the frontal lobe might be helpful in treating the same. Study hypotheses include that rTMS to the dorsolateral prefrontal cortex (DLPFC) will improve apathy and executive function better than sham treatment in those with MCI

NCT ID: NCT02141022 Active, not recruiting - Multiple Sclerosis Clinical Trials

Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya

Start date: August 2013
Phase: N/A
Study type: Interventional

This study is investigating the efficacy of computer-based cognitive exercises as a means of cognitive remediation in patients with Multiple Sclerosis (MS) who are beginning the disease modifying pharmacotherapy Gileyna.

NCT ID: NCT02023645 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

The Effects of a Carotenoid Intervention on Cognitive Function

Start date: January 2012
Phase: N/A
Study type: Interventional

Past research suggests that retinal lutein levels are related to cognitive function as measured via behavioral tests. The goal of the present study is to investigate the relationship between lutein and cognitive function in a wider variety of the population (young, healthy adults and older adults), using a wider variety of methods (behavioral testing and neuroimaging).